Physician
Nguyen, Si
Nguyen, Si was paid $216K by Medicaid between Jan 2018 and Aug 2023, across 61 billing codes. Its largest line is 80053, Comprehensive metabolic panel — 11% of everything it billed.
33Billing provider infoNGUYEN, SI
GARDEN GROVE, CA 92843
GARDEN GROVE, CA 92843
33aNPI1841234952assigned 06/16/2006
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$216K
24GClaims115,220
24DCodes billed61
24AFirst – last monthJan 2018 – Aug 2023
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in California
Rank by total paid#81 of 222
Median peer was paid$42K
This provider vs. median5.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,935 | $19K | |
| 2019 | 13,377 | $30K | |
| 2020 | 18,626 | $45K | |
| 2021 | 26,814 | $42K | |
| 2022 | 30,937 | $55K | |
| 2023 | 15,531 | $25K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80053 | Comprehensive metabolic panel | 11% | 13,768 | 11,237 | $24K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 11% | 3,252 | 3,053 | $23K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 10% | 16,528 | 13,033 | $22K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 8.5% | 379 | 364 | $18K |
| 83880 | 6.5% | 2,337 | 2,091 | $14K | |
| 84484 | 5.8% | 6,107 | 5,180 | $12K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 4.6% | 230 | 214 | $10K |
| 83690 | 4.3% | 7,922 | 7,271 | $9K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 3.3% | 4,863 | 3,615 | $7K |
| 87040 | 3.1% | 2,949 | 2,707 | $7K | |
| 83605 | 3.0% | 3,388 | 2,908 | $7K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.7% | 1,570 | 1,473 | $6K |
49 more codes
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.1% | 1,323 | $4K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.9% | 1,419 | $4K |
| 84145 | 1.7% | 829 | $4K | |
| 87081 | 1.6% | 3,567 | $4K | |
| 81001 | 1.6% | 6,151 | $3K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.6% | 2,454 | $3K |
| 83735 | 1.4% | 2,373 | $3K | |
| 82962 | 1.3% | 5,155 | $3K | |
| 85730 | 1.3% | 2,538 | $3K | |
| 85610 | 1.3% | 3,930 | $3K | |
| 85027 | 1.2% | 2,810 | $3K | |
| 85379 | <1% | 1,224 | $2K | |
| 87428 | <1% | 244 | $2K | |
| 80061 | Lipid panel | <1% | 742 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 948 | $2K |
| 81003 | <1% | 3,945 | $1K | |
| 84100 | <1% | 1,014 | $903.52 | |
| 82728 | <1% | 356 | $831.72 | |
| 87186 | <1% | 425 | $826.41 | |
| 85007 | <1% | 1,458 | $790.19 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 101 | $718.34 |
| 82607 | <1% | 244 | $634.34 | |
| 84702 | <1% | 270 | $624.75 | |
| 82746 | <1% | 239 | $608.38 | |
| 82550 | <1% | 446 | $540.32 | |
| 88312 | <1% | 12 | $519.56 | |
| 87070 | <1% | 585 | $468.40 | |
| 87077 | <1% | 246 | $441.94 | |
| 87088 | <1% | 316 | $426.70 | |
| 83550 | <1% | 310 | $413.36 | |
| 84439 | <1% | 264 | $397.86 | |
| 83540 | <1% | 312 | $339.97 | |
| 87205 | <1% | 394 | $328.27 | |
| 83615 | <1% | 64 | $73.17 | |
| 85651 | <1% | 153 | $71.99 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 49 | $65.93 |
| 84030 | <1% | 53 | $53.46 | |
| 87299 | <1% | 15 | $30.30 | |
| 80320 | <1% | 2,959 | $30.00 | |
| 82009 | <1% | 42 | $28.70 | |
| 86140 | <1% | 29 | $26.15 | |
| 85014 | <1% | 77 | $25.72 | |
| 85018 | <1% | 79 | $25.14 | |
| 87420 | <1% | 34 | $19.09 | |
| 81025 | <1% | 93 | $13.84 | |
| 81005 | <1% | 13 | $4.43 | |
| 84132 | <1% | 13 | $0.69 | |
| 80329 | 0% | 1,540 | $0.00 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 70 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.